Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-028004

Chief Executive Officer gave up 2,352.93 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2023-11-20 Shares withheld for taxes −2,352.93 $148.94 $350,445 438,633 D
Derivatives
Farrell Michael J. Chief Executive Officer 2023-11-16 Grant or award · ResMed Common Stock Options +55,468 $148.90 $8,259,185 55,468 D
Loading xslF345X05/form4.xml…